Regenxbio Stock (NASDAQ: RGNX) stock price, news, charts, stock research, profile.
Open | $14.480 |
Close | $14.350 |
Volume / Avg. | 424.738K / 597.394K |
Day Range | 14.210 - 14.850 |
52 Wk Range | 11.830 - 28.800 |
Market Cap | $706.823M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 10.66% |
Days to Cover | 10.52 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Regenxbio (NASDAQ: RGNX) through any online brokerage.
Other companies in Regenxbio’s space includes: 89bio (NASDAQ:ETNB), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Sage Therapeutics (NASDAQ:SAGE) and CareDx (NASDAQ:CDNA).
The latest price target for Regenxbio (NASDAQ: RGNX) was reported by HC Wainwright & Co. on Wednesday, May 15, 2024. The analyst firm set a price target for 38.00 expecting RGNX to rise to within 12 months (a possible 164.81% upside). 19 analyst firms have reported ratings in the last year.
The stock price for Regenxbio (NASDAQ: RGNX) is $14.35 last updated May 31, 2024 at 4:03 PM EDT.
There are no upcoming dividends for Regenxbio.
Regenxbio’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for Regenxbio.
Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.